SS
WST icon

Steve Schonfeld’s West Pharmaceutical WST Stock Holding History

Steve Schonfeld’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$374K Buy
+1,041
New +$318K ﹤0.01% 1945
2026
Q1 		– Sell
-3,513
Closed -$967K – 2733
2025
Q4 		$967K Buy
3,513
+2,741
+355% +$750K ﹤0.01% 1132
2025
Q3 		$203K Sell
772
-6,361
-89% -$1.55M ﹤0.01% 1944
2025
Q2 		$1.56M Sell
7,133
-6,564
-48% -$1.4M 0.01% 1104
2025
Q1 		$3.07M Buy
+13,697
New +$3.77M 0.02% 742
2024
Q1 		– Sell
-4,600
Closed -$1.62M – 2452
2023
Q4 		$1.62M Buy
+4,600
New +$1.63M 0.01% 870
2023
Q3 		– Sell
-5,914
Closed -$2.26M – 2356
2023
Q2 		$2.26M Buy
+5,914
New +$2.11M 0.02% 713
2023
Q1 		– Sell
-4,413
Closed -$1.04M – 2710
2022
Q4 		$1.04M Sell
4,413
-17,506
-80% -$4.15M 0.01% 1126
2022
Q3 		$5.39M Buy
+21,919
New +$6.68M 0.05% 507
2022
Q2 		– Sell
-2,462
Closed -$1.01M – 3053
2022
Q1 		$1.01M Buy
+2,462
New +$964K 0.01% 985
2021
Q2 		– Sell
-5,652
Closed -$1.59M – 2355
2021
Q1 		$1.59M Buy
5,652
+2,418
+75% +$692K 0.02% 730
2020
Q4 		$916K Sell
3,234
-1,407
-30% -$395K 0.01% 848
2020
Q3 		$1.28M Buy
+4,641
New +$1.23M 0.02% 640
2020
Q1 		– Sell
-3,150
Closed -$474K – 1573
2019
Q4 		$474K Sell
3,150
-4,773
-60% -$695K 0.01% 766
2019
Q3 		$1.12M Buy
+7,923
New +$1.09M 0.03% 446
2019
Q1 		– Sell
-10,444
Closed -$1.02M – 1320
2018
Q4 		$1.02M Buy
+10,444
New +$1.13M 0.04% 475
2018
Q2 		– Sell
-11,641
Closed -$1.03M – 1001
2018
Q1 		$1.03M Buy
+11,641
New +$1.09M 0.08% 318
2017
Q3 		– Sell
-3,107
Closed -$294K – 797
2017
Q2 		$294K Buy
+3,107
New +$286K 0.03% 483
2017
Q1 		– Sell
-9,079
Closed -$770K – 758
2016
Q4 		$770K Sell
9,079
-10,631
-54% -$836K 0.1% 265
2016
Q3 		$1.47M Buy
+19,710
New +$1.56M 0.25% 111

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Steve Schonfeld's WST Position: Q2 2026 in Review

Steve Schonfeld opened a new position in West Pharmaceutical (WST) in Q2 2026: 1,041 shares worth $374K. The stake represents ﹤0.01% of the portfolio and ranks #1945 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in WST as recently as Q4 2025.

Steve Schonfeld first reported a position in WST in Q3 2016 and has held it in 20 quarters since. The position peaked at $5.39M in Q3 2022. 827 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Steve Schonfeld held 1,041 shares of West Pharmaceutical worth $374K as of Q2 2026.
  • West Pharmaceutical was a new Steve Schonfeld position in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #1945 holding.
  • Steve Schonfeld first reported a position in West Pharmaceutical in Q3 2016 and has held it in 20 quarters since.
  • Steve Schonfeld's West Pharmaceutical position peaked at $5.39M in Q3 2022.
  • 827 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.